Literature DB >> 19732857

A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling.

Mark C Peterson1, Matthew M Riggs.   

Abstract

Bone biology is physiologically complex and intimately linked to calcium homeostasis. The literature provides a wealth of qualitative and/or quantitative descriptions of cellular mechanisms, bone dynamics, associated organ dynamics, related disease sequela, and results of therapeutic interventions. We present a physiologically based mathematical model of integrated calcium homeostasis and bone biology constructed from literature data. The model includes relevant cellular aspects with major controlling mechanisms for bone remodeling and calcium homeostasis and appropriately describes a broad range of clinical and therapeutic conditions. These include changes in plasma parathyroid hormone (PTH), calcitriol, calcium and phosphate (PO4), and bone-remodeling markers as manifested by hypoparathyroidism and hyperparathyroidism, renal insufficiency, daily PTH 1-34 administration, and receptor activator of NF-kappaB ligand (RANKL) inhibition. This model highlights the utility of systems approaches to physiologic modeling in the bone field. The presented bone and calcium homeostasis model provides an integrated mathematical construct to conduct hypothesis testing of influential system aspects, to visualize elements of this complex endocrine system, and to continue to build upon iteratively with the results of ongoing scientific research. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732857     DOI: 10.1016/j.bone.2009.08.053

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  66 in total

1.  On the pharmacological evaluation of bisphosphonates in humans.

Authors:  Serge Cremers; Frank Hal Ebetino; Roger Phipps
Journal:  Bone       Date:  2020-06-27       Impact factor: 4.398

2.  Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women.

Authors:  Dhananjay D Marathe; Anshu Marathe; Donald E Mager
Journal:  Biopharm Drug Dispos       Date:  2011-09-22       Impact factor: 1.627

3.  Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Jonathan F French; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-02-12       Impact factor: 2.745

Review 4.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

5.  Intra-skeletal vascular density in a bipedal hopping macropod with implications for analyses of rib histology.

Authors:  Tahlia J Stewart; Julien Louys; Justyna J Miszkiewicz
Journal:  Anat Sci Int       Date:  2021-01-22       Impact factor: 1.741

Review 6.  Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.

Authors:  Jane P F Bai; Justin C Earp; Venkateswaran C Pillai
Journal:  AAPS J       Date:  2019-06-03       Impact factor: 4.009

Review 7.  Pharmacometrics and systems pharmacology for metabolic bone diseases.

Authors:  Matthew M Riggs; Serge Cremers
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

8.  Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.

Authors:  Ping Chen; Adimoolam Narayanan; Benjamin Wu; Per Olsson Gisleskog; John P Gibbs; Andrew T Chow; Murad Melhem
Journal:  Clin Pharmacokinet       Date:  2018-01       Impact factor: 6.447

Review 9.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

10.  Selection and Qualification of Simplified QSP Models When Using Model Order Reduction Techniques.

Authors:  Chihiro Hasegawa; Stephen B Duffull
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.